411 related articles for article (PubMed ID: 20153263)
1. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
[TBL] [Abstract][Full Text] [Related]
2. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
[TBL] [Abstract][Full Text] [Related]
3. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.
Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A
Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443
[TBL] [Abstract][Full Text] [Related]
4. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.
Benedikt A; Baltruschat S; Scholz B; Bursen A; Arrey TN; Meyer B; Varagnolo L; Müller AM; Karas M; Dingermann T; Marschalek R
Leukemia; 2011 Jan; 25(1):135-44. PubMed ID: 21030982
[TBL] [Abstract][Full Text] [Related]
5. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
Yokoyama A
Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
[TBL] [Abstract][Full Text] [Related]
6. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.
Biswas D; Milne TA; Basrur V; Kim J; Elenitoba-Johnson KS; Allis CD; Roeder RG
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15751-6. PubMed ID: 21896721
[TBL] [Abstract][Full Text] [Related]
7. TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.
Okuda H; Takahashi S; Takaori-Kondo A; Yokoyama A
Cell Cycle; 2016 Oct; 15(20):2712-22. PubMed ID: 27564129
[TBL] [Abstract][Full Text] [Related]
8. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.
Mueller D; Bach C; Zeisig D; Garcia-Cuellar MP; Monroe S; Sreekumar A; Zhou R; Nesvizhskii A; Chinnaiyan A; Hess JL; Slany RK
Blood; 2007 Dec; 110(13):4445-54. PubMed ID: 17855633
[TBL] [Abstract][Full Text] [Related]
9. RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation.
Yokoyama A
Front Genet; 2018; 9():722. PubMed ID: 30693017
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation by MLL fusion proteins in leukemogenesis.
Yokoyama A
Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
[TBL] [Abstract][Full Text] [Related]
11. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract][Full Text] [Related]
12. Targeting recruitment of disruptor of telomeric silencing 1-like (DOT1L): characterizing the interactions between DOT1L and mixed lineage leukemia (MLL) fusion proteins.
Shen C; Jo SY; Liao C; Hess JL; Nikolovska-Coleska Z
J Biol Chem; 2013 Oct; 288(42):30585-30596. PubMed ID: 23996074
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
[TBL] [Abstract][Full Text] [Related]
14. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.
Lin C; Smith ER; Takahashi H; Lai KC; Martin-Brown S; Florens L; Washburn MP; Conaway JW; Conaway RC; Shilatifard A
Mol Cell; 2010 Feb; 37(3):429-37. PubMed ID: 20159561
[TBL] [Abstract][Full Text] [Related]
15. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
Bitoun E; Oliver PL; Davies KE
Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
[TBL] [Abstract][Full Text] [Related]
16. AF4 and AF4-MLL mediate transcriptional elongation of 5-lipoxygenase mRNA by 1, 25-dihydroxyvitamin D3.
Ahmad K; Scholz B; Capelo R; Schweighöfer I; Kahnt AS; Marschalek R; Steinhilber D
Oncotarget; 2015 Sep; 6(28):25784-800. PubMed ID: 26329759
[TBL] [Abstract][Full Text] [Related]
17. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia.
Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R
Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834
[TBL] [Abstract][Full Text] [Related]
18. The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.
Bursen A; Schwabe K; Rüster B; Henschler R; Ruthardt M; Dingermann T; Marschalek R
Blood; 2010 Apr; 115(17):3570-9. PubMed ID: 20194896
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of a rare MLL-AF4 (MLL-AFF1) fusion rearrangement in infant leukemia.
Bizarro S; Cerveira N; Correia C; Lisboa S; Peixoto A; Norton L; Teixeira MR
Cancer Genet Cytogenet; 2007 Oct; 178(1):61-4. PubMed ID: 17889710
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.
Sobhian B; Laguette N; Yatim A; Nakamura M; Levy Y; Kiernan R; Benkirane M
Mol Cell; 2010 May; 38(3):439-51. PubMed ID: 20471949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
